The FDA has approved the SAPIEN 3 platform, a TAVR therapy, for patients with severe aortic stenosis without symptoms.

Researchers have developed cutting-edge MRI technology to diagnose a common heart problem more quickly and accurately than ever before. Aortic stenosis is a progressive and potentially fatal condition ...

The benefit of TAVR vs. clinical surveillance for patients with asymptomatic severe aortic stenosis did not vary by age. TAVR was tied to lower stroke risk in the youngest and oldest age groups.

Please provide your email address to receive an email when new articles are posted on . Electronic provider notification led to more aortic valve replacement procedures after a diagnosis of severe ...

Researchers from the University of Sheffield and the University of East Anglia have implemented a cutting-edge 4D flow MRI ...

Aortic stenosis is a progressive and potentially fatal condition, affecting an estimated 300,000 people in the UK. It affects about five per cent of 65-year-olds in the US, with increasing prevalence ...

in patients with aortic stenosis (AS), according to data from the PREFER-CMR registry. The findings are encouraging in the context of the recent approval of TAVI for patients with asymptomatic severe ...

Find out why staging TAVI and PCI lowers risk in complex heart cases - read the latest insights from the ASCoP registry.

In patients greater than age 65, more than 90% of aortic stenosis involves trileaflet valves which have developed heavy calcification. [5] In these instances the calcium deposits are thought to ...

University of East Anglia scientists have developed cutting-edge MRI technology to diagnose a common heart problem more quickly and accurately than ever before.

A new method of alerting clinical care providers holds promise for increasing treatment and improving survival for patients with severe aortic stenosis (AS), a valvular heart condition that can be ...